Effects of an antisense oligonucleotide to pronociceptin and long-term prevention of morphine actions by nociceptin

Peptides

Volumn 21, Issue 7, 2000, Pages 1119-1124

  Candeletti, Sanzio ^a   Ferri, Sergio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antisense oligodeoxynucleotide; Body temperature; Morphine; Nociceptin; Rat; Tail flick

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; MESSENGER RNA; MORPHINE; NOCICEPTIN; PRONOCICEPTIN; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BODY TEMPERATURE; BRAIN; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG POTENTIATION; HYPERTHERMIA; LOCOMOTION; MALE; NEUROMODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANIMALS; BODY TEMPERATURE; BRAIN; MALE; MORPHINE; OLIGONUCLEOTIDES, ANTISENSE; OPIOID PEPTIDES; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; RNA, MESSENGER; TIME FACTORS; VASODILATOR AGENTS;

EID: 0033821692     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00249-7     Document Type: Article

References (45)

1. 2 is an agonist of the nociceptin (ORL1) receptor. Eur J Pharmacol. 349:1998;R5-R6.
2. 2 on nociception in the rat. Life Sci. 66:2000;257-264.
3. 2, a peripheral ORL-1 receptor antagonist, acts as an agonist in the rat spinal cord. Br J Pharmacol. 125:1998;949-951.
4. Connor M., Vaughan C.W., Chieng B., Christie M.J. Nociceptin receptor coupling to potassium conductance in locus coeruleus neurons in vitro. Br J Pharmacol. 119:1996;1614-1618.
5. 2+ in the SH-SY5Y human neuroblastoma cell line. Br J Pharmacol. 118:1997;205-207.
6. Crooke S.T., Bennett C.F. Progress in antisense oligonucleotide therapeutics. Annu Rev Pharmacol Toxicol. 36:1996;107-129.
7. Devine D. P, Taylor L, Reinscheid RK, Monsma FJ, Civelli O, Akil H. Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochem Res. 21:1996;1387-1396.
8. Du L.N., Wu G.C., Cao X.D. Modulation of orphanin FQ or electroacupuncture (EA) on immune function of traumatic rats. Acupunct Electrother Res. 23:1998;1-8.
9. Faber E.S., Chambers J.P., Evans R.H., Henderson G. Depression of glutamatergic transmission by nociceptin in the neonatal rat hemisected spinal cord preparation in vitro. Br J Pharmacol. 119:1996;189-190.
10. Florin S., Suaudeau C. , Meunier J-Cl, Costentin J. Nociceptin stimulates locomotion and exploratory behaviour in mice. Eur J Pharmacol. 317:1996;9-13.
11. Gintzler A.R., Adapa I.D., Toll L., Medina V.M., Wang L. Modulation of enkephalin release by nociceptin. Eur J Pharmacol. 325:1997;29-34.
12. Hara N., Minami T., Okuda-Ashitaka E., et al. Characterization of nociceptin hyperalgesia and allodynia in conscious mice. Br J Pharmacol. 121:1997;401-408.
13. Hulsey M.G., Pless C.M., White B.D., Martin R.J. Icv administration of anti-NPY antisense oligonucleotide effects on feeding behavior, body weight, peptide content and peptide release . Regul Pept. 59:1995;207-214.
14. King M., Chang A., Pasternak G.W. Functional blockade of opioid analgesia by orphanin FQ/nociceptin. Biochem Pharmacol. 55:1998;1537-1540.
15. Köster A., Montrowski A., Schultz S., et al. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc Natl Acad Sci USA. 96:1999;10444-10449.
16. Leventhal L., Mathis J.P., Rossi G.C., Pasternak G.W., Bodnar R.J. Orphan opioid receptor antisense probes block orphanin FQ-induced hyperphagia. Eur J Pharmacol. 349:1998;R1-R3.
17. Leventhal L., Silva R.M., Rossi G.C., Pasternak G.W., Bodnar R.J. Morphine-6β-glucuronide-induced hyperphagia characterization of opioid action by selective antagonists and antisense mapping in rats . J Pharmacol Exp Ther. 287:1998;538-544.
18. Lewis J.W., Sherman J.E., Liebeskind J.C. Opioid and non-opioid stress analgesia assessment of tolerance and cross-tolerance with morphine . J Neurosci. 1:1981;358-363.
19. Liebel J.T., Swandulla D., Zeilhofer H.U. Modulation of excitatory synaptic transmission by nociceptin in superficial dorsal horn neurons of the neonatal rat spinal cord. Br J Pharmacol. 121:1997;425-432.
20. 2+ pathway. Biochem Biophys Res Commun. 240:1997;304-308.
21. Meunier J.C., Mollereau C., Toll L., et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
22. Meunier J.C. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur J Pharmacol. 340:1997;1-15.
23. Minami T., Okuda-Ashitaka E., Nishizawa M., Mori H., Ito S. Inhibition of nociceptin-induced allodynia in conscious mice by prostaglandin D2. Br J Pharmacol. 122:1997;605-610.
24. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O., Belknap J.K., Grandy D.K. Orphanin FQ is a functional anti-opioid peptide. Neuroscience. 75:1996;333-337.
25. Mollerau C., Parmentier M., Mailleux P., et al. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 341:1994;33-38.
26. Mollereau C., Simons M.J., Soularue P., Liners F., Meunier J.C., Parmentier M. Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc Natl Acad Sci USA. 93:1996;8666-8670.
27. Neal C.R., Mansour A., Reinscheid R., et al. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding . J Comp Neurol. 412:1999;563-605.
28. Neal C.R., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., Watson S.J. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J Comp Neurol. 406:1999;503-547.
29. Nishi M., Houtani T., Noda Y., et al. Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphanin FQ receptor. EMBO J. 16:1997;1858-1864.
30. Noble F., Roques B.P. Association of aminopeptidase N and endopeptidase 24. 15 inhibitors potentiate behavioral effects mediated by nociceptin/orphanin FQ in mice. FEBS Lett. 401:1997;227-229.
31. Nothacker H.P., Reinscheid R.K., Mansour A., et al. Primary structure and tissue distribution of the orphanin FQ precursor. Proc Natl Acad Sci USA. 93:1996;8677-8682.
32. Reinscheid R.K., Nothacker H.-P., Bourson A., et al. Orphanin FQ a neuropeptide that activates an opioid like G protein-coupled receptor . Science. 270:1995;792-794.
33. Rossi G.C., Leventhal L., Pasternak G.W. Naloxone sensitive orphanin FQ- induced analgesia in mice. Eur J Pharmacol. 311:1996;R7-R8.
34. Sandin J., Georgieva J., Schott P.A., Ogren S.O., Terenius L. Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. Eur J Neurosci. 9:1997;194-197.
35. Schulz S., Schreff M., Nuss D., Gramsch C., Hollt V. Nociceptin/orphanin FQ and opioid peptides show overlapping distribution but not co-localization in pain-modulatory brain regions. Neuroreport. 7:1996;3021-3025.
36. Spampinato S., Canossa M., Carboni L., Campana G., Leanza G., Ferri S. Inhibition of proopiomelanocortin expression by an oligodeoxynucleotide complementary to β-endorphin mRNA. Proc Natl Acad Sci USA. 91:1994;8072-8076.
37. Stanfa L.C., Chapman V., Kerr N., Dickenson A.H. Inhibitory action of nociceptin on spinal dorsal horn neurons of the rat, in vivo. Br J Pharmacol. 118:1996;1875-1877.
38. Tallarida R.J., Murray R.B. Manual of pharmacologic calculations with computer programs, 2nd Ed. 1987;Springer, New York.
39. Tian J.H., Xu W., Fang Y., Mogil J.S., Grisel J.E., Grandy D.K., Han J.S. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia antagonism in brain and potentiation in spinal cord of the rat . Br J Pharmacol. 120:1997;49-52.
40. Wu Y.L., Pu L., Ling K., Zhao J., Cheng Z.J., Ma L., Pei J. Molecular characterization and functional expression of opioid receptor-like 1 receptor. Cell Res. 7:1997;69-77.
41. Xu X.J., Hao J.X., Wiesenfeld-Hallin Z. Nociceptin or antinociceptin potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat . Neuroreport. 7:1996;2092-2094.
42. Yu J., Chait B.T., Toll L., Kreek M.J. Nociceptin in vitro biotransformation in human blood. Peptides. 17:1996;873-876.
43. Yu T.P., Fein J., Phan T., Evans C.J., Xie C.W. Orphanin FQ inhibits synaptic transmission and long - term potentiation in rat hippocampus. Hippocampus. 7:1997;88-94.
44. Zhu C.B., Cao X.D., Xu S.F., Wu G.C. Orphanin FQ potentiates formalin-induced pain behavior and antagonizes morphine analgesia in rats. Neurosci Lett. 235:1997;37-40.
45. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.